Cargando…
Clinical benefit for clinical sequencing using cancer panel testing
BACKGROUND: Clinical sequencing using a panel of genes has recently been applied worldwide for patients with refractory solid tumors, but the significance of clinical sequencing using gene panel testing remains uncertain. Here we sought to clarify the feasibility and utility of clinical sequencing i...
Autores principales: | Nishimura, Sadaaki, Sugimoto, Atsushi, Kushiyama, Shuhei, Togano, Shingo, Kuroda, Kenji, Yamamoto, Yurie, Yamauchi, Makoto, Sumi, Toshiyuki, Kaneda, Hiroyasu, Kawaguchi, Tomoya, Kato, Minoru, Tagami, Mizuki, Oebisu, Naoto, Hoshi, Manabu, Kimura, Kenjiro, Kubo, Shoji, Muguruma, Kazuya, Takashima, Tsutomu, Ohira, Masaichi, Yashiro, Masakazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909652/ https://www.ncbi.nlm.nih.gov/pubmed/33635883 http://dx.doi.org/10.1371/journal.pone.0247090 |
Ejemplares similares
-
Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer
por: Yashiro, Masakazu, et al.
Publicado: (2021) -
Circulating tumor cells with FGFR2 expression might be useful to identify patients with existing FGFR2‐overexpressing tumor
por: Kuroda, Kenji, et al.
Publicado: (2020) -
Lipocalin-2 negatively regulates epithelial–mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancer
por: Nishimura, Sadaaki, et al.
Publicado: (2022) -
Gastric cancer stem cells survive in stress environments via their autophagy system
por: Togano, Shingo, et al.
Publicado: (2021) -
Clinicopathologic significance of TROP2 and phospho-TROP2 in gastric cancer
por: Kushiyama, Shuhei, et al.
Publicado: (2021)